Industry Information

The preparation process of Urofollitropin

  With the rapid development of modern society, the incidence of infertility is increasing year by year. At present, about 15% of couples of childbearing age are facing fertility problems, and there is an increasing trend. Oligospermozoospermia is the most common cause of male infertility. The pathogenesis of severe oligo asthenozoospermia has not been fully clarified, and drugs with clear curative effects are still rare, which is one of the most difficult problems for clinicians. The necessity of follicle-stimulating hormone (FSH) in regulating and maintaining human spermatogenesis is well known, and FSH plays an important role in maintaining Sertoli cell function as well as in spermatogenesis.

The preparation process of Urofollitropin

  Urofollitropin (urine Follicle Stimulating Hormone, u-FSH) is a composition whose main component is Follicle Stimulating Hormone (FSH). The FSH content in high-purity Urofollitropin can reach more than 95%, and it hardly contains Luteotropic Hormone (LH). FSH is a glycoprotein hormone with a molecular weight of about 30KD. FSH can promote the proliferation of granulosa cells, stimulate steroid production, regulate the development and maturation of gametocytes, and is one of the main hormones in the hypothalamus-pituitary-gonad axis.

  FSH has the functions of regulating the menstrual cycle, ovulation, and regulating male testicular function in humans. It is commonly used clinically to treat female infertility, insufficient secretion of male gonadotropin, and deficient seminiferous tubules. In the human pituitary gland and in the urine of menopausal and postmenopausal women, the content of the two is higher, so it is also the main source of extracting FSH. The raw material for the production of u-FSH is human menopausal gonadotropin (Human Menopausal Gonadotropin, HMG), which mainly includes follicle-stimulating hormone and luteinizing hormone (Luteotropic Hormone, LH). The ratio of FSH to LH titer is about 1:1. To prepare high-purity Urofollitropin, LH and other urinary proteins in HMG need to be removed, and FSH, which is a single active component of high purity, should be retained.